Xinjiang Tefeng Pharmaceutical

Xinjiang Tefeng Pharmaceutical is a leading Chinese pharmaceutical enterprise specializing in the development and production of ethnic Uyghur medicines and chemical drugs. Headquartered in Urumqi, the company leverages the unique medicinal resources of the Xinjiang region to create specialized treatments for dermatology, cardiovascular health, and respiratory conditions. Their flagship products, such as Compound Kaliziri Tincture, are widely recognized for treating vitiligo and other skin disorders. The company operates multiple GMP-certified production lines and maintains a robust research and development infrastructure dedicated to modernizing traditional ethnic prescriptions. Xinjiang Tefeng is listed on the National Equities Exchange and Quotations (NEEQ) and continues to expand its footprint in both domestic and international markets.